TAIPEI — ProLogium Holding Inc. announced on Saturday, August 8, 2026, that it secured commitments for a $50 million primary capital investment from a consortium of existing shareholders. The funding round is anchored to the company's established pre-money valuation of approximately $3.8 billion. The capital injection is structured to support the ongoing scale-up of next-generation lithium ceramic battery production and accelerate the construction of ProLogium's planned manufacturing gigafactory located in Dunkirk, France.
Corporate executives stated that the financing forms an integral component of the previously announced target capital raise tied to ProLogium's upcoming business combination with Translational Development Acquisition Corp., a special purpose acquisition company traded on the Nasdaq under the ticker TDAC. Founder and Chief Executive Officer Vincent Yang noted that the committed funds reflect strong institutional confidence in the company's proprietary superfluidized all-inorganic solid-state battery technology and commercial execution strategy.
Engineering teams at the company's Taiwan headquarters and European facilities are finalizing equipment placement timelines ahead of upcoming operational milestones. Financial advisors and legal representatives for both entities are completing regulatory filing requirements for the transaction sequence. The formal shareholder vote and closing procedures for the business combination agreement are scheduled for completion on September 29, 2026.
Why did ProLogium secure this $50 million primary capital investment?
ProLogium secured the $50 million primary capital investment to support the commercial scale-up of its next-generation lithium ceramic solid-state battery manufacturing operations and to advance construction on its large-scale gigafactory project in Dunkirk, France.
The definitive proxy filing and registration documents related to the transaction are scheduled for release on September 1, 2026.